Učitavanje...
Economic consequences of idiopathic pulmonary fibrosis in Denmark
When a patient is diagnosed with IPF, the net health costs increase from €2753 to €21 184 per year even without the cost of antifibrotic treatment. Inpatient treatment accounts for the main part of the expenses http://ow.ly/dSsn30jEx0p
Spremljeno u:
| Izdano u: | ERJ Open Res |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
European Respiratory Society
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5968194/ https://ncbi.nlm.nih.gov/pubmed/29850467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00045-2017 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|